Parkinson's Disease Trial, Recruiting NCT06416722 Sponsor: Fenerbahce University Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06416722
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with idiopathic Parkinson's Disease (Parkinson's that does not have a known outside cause)
  • Your Parkinson's is at a mild to moderate stage (Stage 1-3 on a standard Parkinson's rating scale)
  • You scored at least 21 out of 30 on a standard memory and thinking test called the Montreal Cognitive Assessment
  • Your Parkinson's medication has stayed the same for at least the last month
  • You are in your medication's "On" period, meaning your medication is currently working and your symptoms are being managed
  • You are able to walk on your own on flat ground without needing someone to physically help you

Who may not be able to join:

  • You have serious problems with your hearing or vision
  • You have another condition affecting your nerves, heart, or bones and joints that makes walking difficult or unsafe
  • You have another neurological condition, such as dementia or a history of stroke
  • You have fewer than 5 years of formal education
  • You have problems with the blood vessels in your legs (confirm with trial site)
  • You do not have access to the internet through a smartphone or computer

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 05071180878

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fenerbahce University
Registry
ClinicalTrials.gov
Start date
1 September 2024
Est. completion
1 December 2025

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Feasibility Assessment; Digit Span Test; Mental Flexibility; Word Fluency Test; Gait Assessment; Mini-BEST Test; Four-step square test; Postural Stability Assessment; Parkinson's Activity Scale; Dual Task Questionnaire

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov